title: Occurrence of Sjögren syndrome in a long-term survivor patient with metastatic colon carcinoma treated with GOLFIG regimen.
authors.forename: Sara
authors.initials: S
authors.lastname: Tenti
authors.forename: Pierpaolo
authors.initials: P
authors.lastname: Correale
authors.forename: Raffaele
authors.initials: R
authors.lastname: Conca
authors.forename: Pierpaolo
authors.initials: P
authors.lastname: Pastina
authors.forename: Antonella
authors.initials: A
authors.lastname: Fioravanti
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D059250:Administration, Metronomic; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy* / Q000276:immunology / Q000556:secondary; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000276:immunology; D003841:Deoxycytidine / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007279:Injections, Subcutaneous; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002955:Leucovorin / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000556:secondary; D008207:Lymphatic Metastasis / Q000276:immunology / Q000517:prevention & control; D060046:Maintenance Chemotherapy; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D012074:Remission Induction; D012859:Sjogren's Syndrome / Q000139:chemically induced* / Q000276:immunology; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; C508594:IL2 protein, human; D007376:Interleukin-2; D009944:Organoplatinum Compounds; D003841:Deoxycytidine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D002955:Leucovorin; D005472:Fluorouracil